Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Time-series expression of toll-like receptor 4 signaling in septic mice treated with mesenchymal stem cells
 
  • Details
Options

Time-series expression of toll-like receptor 4 signaling in septic mice treated with mesenchymal stem cells

Journal
Shock
Date Issued
2016-06-01
Author(s)
KANG-HSI WU  
YU-HUA CHAO  
DOI
10.1097/SHK.0000000000000546
URI
https://www.scopus.com/pages/publications/84950107520
https://scholars.csmu.edu.tw/handle/123456789/24448
Abstract
Sepsis remains an important cause of mortality worldwide, and early deaths resulting from overwhelming inflammation in septic patients have been reported. Vigorous immune reactions are beneficial for bacterial clearance in this circumstance but at the price of self-tissue damage. Mesenchymal stem cells (MSCs) have been found to modulate immune function and attenuate sepsis.As the Toll-like receptor 4 pathway plays an important role in response to infections, here we investigated the mechanisms of MSC-mediated immunomodulation by determining the expression of Toll-like receptor 4 signaling in the liver and by circulating cytokines at 0, 1, 2, 3, and 6 h after cecal ligation and puncture (CLP)-induced sepsis in mice. We found that administration of umbilical cord-derived MSCs (UCMSCs) was beneficial for survival. Six hours after CLP, UCMSC administration decreased the expression of MyD88 mRNA and protein in the liver tissues of themice, and also the ratio ofNFkBphosphorylation (P=0.041 and 0.005, respectively). Serumlevels of TNF-a, MCP-1, IFN-g, and IL-6 were significantly lower and IL-10 significantly higher 6 h after CLP in themice receiving UCMSCs compared with those receiving PBS only. Our study provides the first in vivo evidence for the association of the MyD88-NFkB pathway and MSC-mediated immunomodulation during sepsis. The immunomodulatory effect of UCMSCs was noted from 3 to 6 h after injection, and the MyD88-NFkB pathway played an important role in response to the immunomodulatory signals from UCMSCs.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback